A PET scan of a human brain with Alzheimer's disease, from the US National Institute on Aging. Health Actinogen locks Alzheimer trial database, narrowing Xanamem topline results to mid-November Mono Scoops 20h Actinogen Medical said its pivotal XanaMIA trial of oral Xanamem in Alzheimer's disease has reached database lock, narrowing guidance for final topline results to mid-November 2026 from November. Read Full Story
